In order to comprehensively assess the tumor microenvironment, we applied the “ESTIMATE” package to calculate the stromal score, immune score, and ESTIMATE score and inferred the tumor purity between the BCR high-risk and low-risk groups of prostate cancer. This evidence concerns the gene BCR and prostate carcinoma.